Skip to main content
SpringerLink
Log in
Book cover

Tumeurs malignes rares pp 59–60Cite as

Localisation thyroïdienne

  • Chapter

  • 60 Accesses

Résumé

La plupart des lymphomes de la thyroïde sont des lymphomes non hodgkiniens. Ils sont rares, représentant 2,5 % de tous les lymphomes et moins de 5 % des tumeurs malignes de la thyroïde (1). Les lymphomes de bas grade surviennent chez des sujets âgés, le plus souvent dans le contexte d’une thyroïdite d’Hashimoto (2). Le pic d’incidence survient pendant la septième décennie avec un ratio homme/femme de 1∶3.

This is a preview of subscription content, log in via an institution.

Références

  1. Freeman C, Berg J, Culter S (1977) Occurrence and prognosis of extranodal lymphoma. Pathologic project 1982 National Cancer Institute sponsored study of classifications of non-Hodgkin’s lymphomas. Summary and description of a Working Formulation for a clinical usage. Cancer 49: 2112–35

    Google Scholar 

  2. Holm LE, Blomgren H, Lowhagen T (1985) Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 312: 601–4

    Article  CAS  PubMed  Google Scholar 

  3. Matsuzuka F, Miyauchi A, Katayama S, et al. (1993) Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases. Thyroid 3: 93–9

    Article  CAS  PubMed  Google Scholar 

  4. Pedersen RK, Pedersen NT (1996) Primary non-Hodgkin lymphoma of the thyroid gland: a population based study. Histopathology 28: 25–32

    Article  CAS  PubMed  Google Scholar 

  5. Isaacson P, Wright DH (1984) Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer 53: 2515–24

    Article  CAS  PubMed  Google Scholar 

  6. Derringer GA, Thompson LD, Frommelt RA, et al. (2000) Malignant lymphoma of the thyroid gland: A clinicopathologic study of 108 cases. Am J Surg Path 24: 623–39

    Article  CAS  PubMed  Google Scholar 

  7. Tsang RW, Gospodarowicz MK, Sutcliffe SB, et al. (1993) Non-Hodgkin’s lymphoma of the thyroid gland: prognostic factors and treatment outcome. Int J Radiation Oncol Biol Phys 27: 559–604

    Google Scholar 

  8. Lister TA, Crowther D, Sutcliffe SB, et al. (1989) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin’s disease: Cotswolds Meeting, J Clin Oncol 11: 1630–6. Erratum in: J Clin Oncol (1990) 8: 1602

    Google Scholar 

  9. Shipp M for The International Non-Hodgkin’s Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med 329: 987–94

    Article  Google Scholar 

  10. Coiffier B, Lepage E, Briere J, et al. (2002) CHOP chemotherapy plus Rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Eng J Med 346: 235–42

    Article  CAS  Google Scholar 

  11. Belal AA, Allam A, Kandil A, et al. (2001) Primary thyroid lymphoma: a retrospective analysis of prognostic factors and treatment outcome for localized intermediate and high-grade lymphoma. Am J Clin Oncol 24: 299–305

    Article  CAS  PubMed  Google Scholar 

  12. DiBiase SJ, Griqsby PW, Guo C, et al. (2004) Outcome analysis for stage IE and IIE thyroid lymphoma. Am J Clin Oncol 27: 178–84

    Article  PubMed  Google Scholar 

  13. Mack LA, Pasieka JL (2007) An evidence-based approach to the treatment of thyroid lymphoma. World J Surg 5: 978–86

    Article  Google Scholar 

  14. Miller TP, Dahlberg S, Cassady JR, et al. (1998) Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate — and high-grade Non-Hodgkin’s Lymphoma. N Engl J Med 339: 21–6

    Article  CAS  PubMed  Google Scholar 

  15. Laing RW, Hoskin P, Hudson BV, et al. (1994) The significance of MALT histology in thyroid lymphoma: a review of patients from BNLI and Royal Marsden Hospital. Clin Oncol 6: 300–4

    Article  CAS  Google Scholar 

  16. Tsang RW, Gosodarowicz MK, Pintilie M, et al. (2003) Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol 21: 4157–64

    Article  PubMed  Google Scholar 

  17. Leedman PJ, Sheridan WP, Downey WF, et al. (1990) Combination chemotherapy as single modality therapy for stage IE and IIE thyroid lymphoma. Med J Aust 152: 40–3

    CAS  PubMed  Google Scholar 

  18. Doria R, Jekel JF, Cooper DL (1994) Thyroid lymphoma: the case for combined modality therapy. Cancer 73: 200–6

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Département de médecine, Institut Gustave-Roussy, 39-42, rue Camille-Desmoulins, 94800, Villejuif

    Christophe Fermé

  2. Service de médecine nucléaire et de cancérologie endocrinienne Institut de cancérologie Gustave-Roussy, Université Paris-Sud XI, 39-42, rue Camille-Desmoulins, 94800, Villejuif

    Martin Schlumberger

Authors
  1. Christophe Fermé
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martin Schlumberger
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Fermé, C., Schlumberger, M. (2010). Localisation thyroïdienne. In: Tumeurs malignes rares. Springer, Paris. https://doi.org/10.1007/978-2-287-72070-3_10

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-72070-3_10

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-72069-7

  • Online ISBN: 978-2-287-72070-3

Publish with us

Policies and ethics

Search

Navigation